Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
GLP-1-based care has given many patients a new path but it must be used responsibly
Healthy Weight and Growth
By mimicking the natural hormone GLP-1, these medications offer a multifaceted approach to managing blood sugar, reducing appetite, promoting weight loss, and even improving cardiovascular health
Individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid GLP-1 receptor agonists
Add bacteriostatic water slowly down the inner wall of the vial containing lyophilized retatrutide